Latest pharma updates on Oncology

FDA Approves Durvalumab (Imfinzi) + FLOT Regimen for Resectable Gastric & GEJ Cancer

The U.S. FDA has given the green light to AstraZeneca’s durvalumab (Imfinzi) in combination with the FLOT chemothe...

Read Full Story
PharmaTradZ Logo

Advertise on PharmaTradZ

Reach verified pharma buyers, suppliers & decision makers worldwide.

Discover Opportunities
PharmaTradZ Logo

Explore Pharma Investment Opportunities

Connect with partners, startups & ventures driving the future of pharma.

Discover Opportunities
PharmaTradZ Logo

Grow Your Pharma Brand

Advertise on the fastest-growing B2B pharma marketplace.

Start Advertising

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
Join WhatsApp Group for Latest Updates
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.